Shareholders Equity ratio Analysis of Teva Pharma Industries Ltd. - Deep Dive


Shareholders Equity of TEVA
Dec-23
17.26
Poor Shareholders Equity
Dec-22
19.75
Poor Shareholders Equity
Growth
-12.59
%
Shareholders Equity Analysis of Teva Pharma Industries Ltd.
Shareholders Equity Ratio of TEVA has fallen by -12.59 % Compared to previous Financial Year.
Shareholders Equity Ratio with value of 24.31 was highest in Year Dec-19 in last Five Years.
Shareholders Equity Ratio with value of 17.26 was lowest in Year Dec-23 in last Five Years.
Latest Shareholders Equity Ratio with value of 17.26 is lower than Average Shareholders Equity of 20.54 in last five years.
Other Shareholders Equity Related Info of TEVA that may interest you.
Teva Pharma Industries Ltd. Overview
CodePricePrevious PricePrice ChangeSector
TEVA17.1617.4 1.38 % Drug Manufacturers-Specialty & Generic
Fundamental AnalysisTechnical Analysis
Defination of Shareholders Equity
The Shareholders Equity Ratio measures how much the company's assets are funded using shareholder's equity instead of debt. This metric also tells how much shareholders claim on the company's assets in a time of liquidation.    more ..
Shareholders Equity Formula

Shareholders Equity Related Ratios
DebtToEquityRatioReturnOnEquity

Tsr Stability Index
Poor Stability Stock
FY - Historical Shareholders Equity of Teva Pharma Industries Ltd.
PeriodDec-23Dec-22Dec-21Dec-20Dec-19Dec-18Dec-17
Shareholders Equity17.2619.7521.5619.8024.3124.2424.58
Change-12.59 %-8.41 %8.91 %-18.56 %0.314 %-1.41 %-31.50 %
You are view first 7 Records. Log in to view all 38 in Premium view
FY Chart of Shareholders Equity of Teva Pharma Industries Ltd.


Note : All Data Generated at the End of Trading Hours (EOD Data)